Roundhill Glp-1 & Weight Loss ETF OZEM
28.76 USD -0.59 (-2.02%)
Regular-session close
28.75 -0.01 -0.05%
After hours · Nov 20, 4:52 PM ET
28.68 Day range 29.46
28.34 52-week range 37.15
- YTD
- -15.80%
- 1 year
- -10.26%
Roundhill Investments - GLP-1 & Weight Loss ETF
- Issuer
- Roundhill Investments
- Asset class
- Equity
- Expense ratio
- 0.59%
- Assets under management
- $53.92M
- NAV
- 29.47
- Holdings
- 29
- Inception
- 2024-05-21
- Top 10 weight
- 72.20%
Top holdings
- LLY Eli Lilly & Co 20.46%
- NVO Novo Nordisk A/S 10.82%
- 4519.T Chugai Pharmaceutical Co Ltd 7.23%
- 128940.KS Hanmi Pharm Co Ltd 6.93%
- PFE Pfizer Inc 5.81%
- 1093.HK CSPC Pharmaceutical Group Ltd 4.77%
- KLRA Kailera Therapeutics Inc 4.57%
- 1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd 4.13%
- 3692.HK Hansoh Pharmaceutical Group Co Ltd 3.77%
- VKTX Viking Therapeutics Inc 3.72%
- 1672.HK Ascletis Pharma Inc 3.29%
- AZN AstraZeneca PLC 3.28%
- AMGN Amgen Inc 3.00%
- ZEAL.CO Zealand Pharma A/S 2.99%
- ROP.SW Roche Holding AG 2.81%
- GPCR Structure Therapeutics Inc 2.71%
- 3933.HK United Laboratories International Holdings Ltd/The 2.06%
- GUBRA.CO Gubra A/S 2.00%
- 1801.HK Innovent Biologics Inc 1.85%
- MBX MBX Biosciences Inc 1.76%
- GILD Gilead Sciences Inc 1.47%
- FGXXX First American Government Obligations Fund 12/01/2031 0.73%
- Cash & Other 0.32%
- CHF SWISS FRANC -0.47%
Sector weights
- Healthcare 100.00%
Country weights
- United States 46.24%
- Denmark 17.42%
- China 12.83%
- Japan 6.59%
- Hong Kong 5.11%
- United Kingdom 4.25%
- South Korea 4.02%
- Switzerland 3.53%
Updated 2026-11-20
